PDCD1 and non-small cell lung carcinoma: We interestingly observed that CTC detection using ISET was associated with reduced PFS among patients with NSCLC receiving anti-PD-1 treatment, corroborating previous evidence supporting the prognostic value of CTCs detected by ISET among patients treated with nivolumab [55].